Dasatinib-Related Effusion Lymphoma in a Patient Treated for Chronic Myeloid Leukaemia


Cytopathology. 2020 Jul 18. doi: 10.1111/cyt.12890. Online ahead of print.


This report presents the clinical, cytological and molecular features of a pleural effusion lymphoma which developed in a patient treated for chronic myeloid leukaemia after five years of dasatinib therapy. This effusion lymphoma recurred three times but largely resolved after pleurocentesis and steroid treatment. More reports on such unusual cases may improve our understanding and management of patients with this rare adverse effect associated with dasatinib.